immunoconjugate
Term · Oncology and biomedicine · MLC-T-ONC-004217
An agent made up of an immune substance, such as a monoclonal antibody, that is chemically linked to a cell-killing substance such as a toxin, a radioactive molecule, or a drug. The antibody part of the immunoconjugate targets cancer cells and the linked substance may kill the cells or make them visible in the body. Some immunoconjugates are used to treat cancer or to help find cancer cells in the body.
| Identifier | MLC-T-ONC-004217 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004217",
"term": "immunoconjugate",
"field": "Oncology and biomedicine",
"definition": "An agent made up of an immune substance, such as a monoclonal antibody, that is chemically linked to a cell-killing substance such as a toxin, a radioactive molecule, or a drug. The antibody part of the immunoconjugate targets cancer cells and the linked substance may kill the cells or make them visible in the body. Some immunoconjugates are used to treat cancer or to help find cancer cells in the body.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/immunoconjugate/"
}
Record 9,091 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.